Literature DB >> 19185818

Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.

John F Hernandez1, Janet A Secrest, Linda Hill, S Jack McClarty.   

Abstract

Malignant hyperthermia (MH), a potentially fatal disorder triggered by certain types of general anesthesia, has received much attention in the scientific literature. From the first case report in 1960 until the present, hundreds of studies have been conducted. The diagnosis of MH has evolved from subjective assumptions by family history and clinical diagnosis to more sophisticated laboratory testing. A genetic basis for MH was recognized in the early 1990s and, since then, complex genetic pathways have been demonstrated. The purpose of this paper is to summarize the research literature on what is known scientifically about the diagnosis and genetic basis of MH.

Entities:  

Mesh:

Year:  2009        PMID: 19185818     DOI: 10.1016/j.jopan.2008.12.001

Source DB:  PubMed          Journal:  J Perianesth Nurs        ISSN: 1089-9472            Impact factor:   1.084


  3 in total

1.  Effect of ulinastatin, a human urinary protease inhibitor, on heatstroke-induced apoptosis and inflammatory responses in rats.

Authors:  Zhen Tao; Feng-Qing Hu; Chuan-Fen Li; Tao Zhang; Bing-Zhen Cao; Lian-Qi Cui
Journal:  Exp Ther Med       Date:  2016-11-23       Impact factor: 2.447

2.  Effects of ulinastatin administered at different time points on the pathological morphologies of the lung tissues of rats with hyperthermia.

Authors:  Zai-Sheng Qin; Pei Tian; Xia Wu; Hong-Mei Yu; Na Guo
Journal:  Exp Ther Med       Date:  2014-04-01       Impact factor: 2.447

3.  Malignant hyperthermia.

Authors:  Dong-Chan Kim
Journal:  Korean J Anesthesiol       Date:  2012-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.